Both in Health Services
Cryo-Cell International vs BioRestorative Therapies, Inc. Common Stock (NV)
Over the past year CCEL returned +16.9% and BRTX returned −94.8%; their daily moves had a correlation of 0.02.
CCEL +16.9% BRTX −94.8%Growth of $1, one year, split-adjusted
| Metric | CCEL | BRTX |
|---|---|---|
| Price | $5.07 | $1.51 |
| Market cap | $40.9M | $2.1M |
| Today | +0.40% | +2.03% |
| 1 month | +30.7% | −33.5% |
| 6 months | +43.6% | −69.2% |
| Year to date | +47.4% | −93.6% |
| 1 year | — | −95.0% |
| Revenue growth (YoY) | 0.0% | −7.3% |
| Gross margin | 79.4% | 68.1% |
| Net margin | 16.2% | −9298.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.3× | 5.8× |
| Net cash | -$4.9M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 886.6% |
| Short % of float | 0.2% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).